Both germline and somatic BARD1 mutations have been described in pancreatic cancer, supporting BARD1’s role in tumor suppression; as such, BARD1 is currently included in germline mutation testing panels, along with other DNA repair genes [9,46,47]. The gene discussed is BARD1; the disease is pancreatic neoplasm.